Delivery Order SPE2DB20D2014-SPE2DB25FC30U
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,842.20 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.61 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal government's...
- The Defense Logistics Agency awarded a $27,345.32 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,917.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention,...
- The Defense Logistics Agency awarded a delivery order valued at $5,900.78 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 8, 2025, with a completion date of August 11, 2025. This competitively awarded, non-set-aside firm fixed price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the Department of Defense's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units, valued at $8,697.19 under a firm fixed price arrangement. This non-set-aside delivery order, issued on August 12, 2025, with completion scheduled for August 13, 2025, will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $30,140.34 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units, valued at $28,822.69. This firm fixed-price delivery order, which is not set-aside, was awarded on July 8, 2025, with an ultimate completion date of July 9, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an HIV prevention and treatment medication, reflecting the company's role as a...
- The Defense Logistics Agency awarded a delivery order valued at $15,530.23 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 16, 2025, with a completion date of September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,954.30 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC30UDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,984.88 for DESCOVY 200-25 mg tablets (30-count units) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting the Defense Logistics Agency's medical supply chain operations supporting military healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical federal vendor supplying brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support defense and military healthcare programs globally. The company's competitive selection and track record of fulfilling federal medical procurement requirements across a diverse product portfolio demonstrates its capability to meet the Defense Logistics Agency's pharmaceutical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 6/25/25 |